Microsatellites may be associated with poorer survival outcomes in melanoma

Source: Healio Dermatology, November 2022

The presence of microsatellites was associated with poorer overall survival in a retrospective cohort of patients with cutaneous melanoma, according to a study.

“There is limited information on microsatellite survival outcomes in melanoma patients,” Constanza Riquelme Mc Loughlin, PhD, MD, of the dermatology department at the Hospital Clinic of Barcelona at the University of Barcelona, Spain, and colleagues wrote.

In the current retrospective analysis, Riquelme Mc Loughlin and colleagues determined survival outcomes in patients with microsatellites and assessed the role of those microsatellites in stage III stratification of American Joint Committee on Cancer (AJCC) classification. They also evaluated results of sentinel lymph node biopsies in patients with microsatellites, according to the findings.
READ THE ORIGINAL FULL ARTICLE